SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $509,000 | +2445.0% | 2,996 | +1602.3% | 0.03% | +2700.0% |
| Q1 2020 | $20,000 | -71.8% | 176 | -71.6% | 0.00% | -75.0% |
| Q4 2019 | $71,000 | +3450.0% | 620 | +1575.7% | 0.00% | – |
| Q2 2017 | $2,000 | -77.8% | 37 | -73.9% | 0.00% | -100.0% |
| Q1 2017 | $9,000 | -18.2% | 142 | -27.9% | 0.00% | -50.0% |
| Q3 2016 | $11,000 | +37.5% | 197 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $8,000 | -11.1% | 197 | -26.8% | 0.00% | 0.0% |
| Q1 2016 | $9,000 | +12.5% | 269 | +57.3% | 0.00% | -33.3% |
| Q4 2015 | $8,000 | 0.0% | 171 | -21.6% | 0.00% | +50.0% |
| Q3 2015 | $8,000 | 0.0% | 218 | +27.5% | 0.00% | 0.0% |
| Q2 2015 | $8,000 | +33.3% | 171 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $6,000 | – | 171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |